Literature DB >> 17903691

Masked hypertension in type 2 diabetes mellitus. Relationship with left-ventricular structure and function.

Chiara Marchesi1, Andrea Maria Maresca, Francesco Solbiati, Ivano Franzetti, Emanuela Laurita, Eleonora Nicolini, Monica Gianni, Luigina Guasti, Patrizio Marnini, Achille Venco, Anna Maria Grandi.   

Abstract

BACKGROUND: To evaluate in type 2 diabetes mellitus the relationship between masked hypertension (MH) and left ventricular (LV) morpho-functional characteristics.
METHODS: Using 24-hour BP monitoring and echocardiography, we evaluated 71 type 2 diabetic patients, without overt cardiac disease and never treated with antihypertensive drugs: 45 normotensive subjects with clinic BP <130/85 mmHg and 26 sustained hypertensives (SH)(clinic BP > or = 140 and/or 90 mmHg and 24-hour BP > or =125 and/or 80 mmHg), matched for age, gender, BMI and duration of diabetes with clinically normotensive patients. MH was diagnosed with clinic BP <130/85 mmHg and 24-hour BP > or =125 and/or 80 mmHg.
RESULTS: Among clinically normotensive patients, 21 (47%) had MH and 24 were true normotensive (NT, 24-hour BP <125/80 mmHg). LV mass increased from NT to MH to SH (p < 0.001); the parameters of LV diastolic function were similar between MH and SH and significantly lower than in NT.
CONCLUSION: In type 2 diabetic patients with clinic BP <130/85 mmHg, MH is frequent and is associated with LV remodelling characterized by increased myocardial mass and preclinical impairment of LV diastolic function; the remodelling is qualitatively and for some aspects also quantitatively similar to that found in sustained hypertensive patients. Therefore it would be useful to look for MH in diabetic subjects with clinic BP <130/85 mmHg, who, following the guidelines, are not entitled to antihypertensive treatment: the finding of MH could identify a subgroup of patients at higher cardiovascular risk and therefore needing a prompt antihypertensive treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17903691     DOI: 10.1016/j.amjhyper.2007.06.005

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  6 in total

1.  Alterations in diastolic function in masked hypertension: findings from the masked hypertension study.

Authors:  Yukiko Oe; Daichi Shimbo; Joji Ishikawa; Kazue Okajima; Takuya Hasegawa; Keith M Diaz; Paul Muntner; Shunichi Homma; Joseph E Schwartz
Journal:  Am J Hypertens       Date:  2013-02-27       Impact factor: 2.689

2.  Masked nocturnal hypertension--a novel marker of risk in type 2 diabetes.

Authors:  M Wijkman; T Länne; J Engvall; T Lindström; C J Ostgren; F H Nystrom
Journal:  Diabetologia       Date:  2009-04-25       Impact factor: 10.122

Review 3.  Ambulatory blood pressure monitoring in the diagnosis and management of hypertension.

Authors:  Ehud Grossman
Journal:  Diabetes Care       Date:  2013-08       Impact factor: 19.112

4.  Association of ACE2 genetic polymorphisms with hypertension-related target organ damages in south Xinjiang.

Authors:  Yi Luo; Cheng Liu; Tianwang Guan; Yanfang Li; Yanxian Lai; Fang Li; Haiyan Zhao; Tutiguli Maimaiti; Abudurexiti Zeyaweiding
Journal:  Hypertens Res       Date:  2018-12-12       Impact factor: 3.872

Review 5.  Should 24-h ambulatory blood pressure monitoring be done in every patient with diabetes?

Authors:  Gianfranco Parati; Grzegorz Bilo
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

6.  Association between retinal arterial narrowing and left ventricular diastolic dysfunction in masked hypertensives.

Authors:  Huiling Huang; Yalin Cao; Jiayong Li; Chen Liu; Marvin Owusu-Agyeman; Baolin Chen; Ling Li; Fawang Du; Xingwei Hu; Yanqiu Liu; Min Ye; Bin Dong; Ruicong Xue; Yugang Dong; Fengjuan Yao
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-05-19       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.